HK78197A - Medicaments for treating gastrointestinal disorders - Google Patents

Medicaments for treating gastrointestinal disorders

Info

Publication number
HK78197A
HK78197A HK78197A HK78197A HK78197A HK 78197 A HK78197 A HK 78197A HK 78197 A HK78197 A HK 78197A HK 78197 A HK78197 A HK 78197A HK 78197 A HK78197 A HK 78197A
Authority
HK
Hong Kong
Prior art keywords
gastrointestinal disorders
medicaments
treating gastrointestinal
pharmaceutical compositions
compositions containing
Prior art date
Application number
HK78197A
Other languages
English (en)
Inventor
Andrew Alexander Mccolm
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of HK78197A publication Critical patent/HK78197A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK78197A 1991-09-20 1997-06-12 Medicaments for treating gastrointestinal disorders HK78197A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919120131A GB9120131D0 (en) 1991-09-20 1991-09-20 Medicaments

Publications (1)

Publication Number Publication Date
HK78197A true HK78197A (en) 1997-06-20

Family

ID=10701750

Family Applications (1)

Application Number Title Priority Date Filing Date
HK78197A HK78197A (en) 1991-09-20 1997-06-12 Medicaments for treating gastrointestinal disorders

Country Status (26)

Country Link
US (3) US5629297A (no)
EP (1) EP0533281B1 (no)
JP (1) JPH0692850A (no)
KR (1) KR100257367B1 (no)
AT (2) ATE228835T1 (no)
BE (1) BE1005808A5 (no)
CA (1) CA2078579A1 (no)
CH (1) CH685372A5 (no)
CY (1) CY2012A (no)
CZ (1) CZ282840B6 (no)
DE (1) DE69232864T2 (no)
ES (1) ES2188582T3 (no)
FR (1) FR2682040B1 (no)
GB (2) GB9120131D0 (no)
HK (1) HK78197A (no)
HU (1) HU211170A9 (no)
IE (1) IE922673A1 (no)
IL (1) IL103213A (no)
IT (1) IT1262993B (no)
MX (1) MX9205313A (no)
NO (1) NO301456B1 (no)
NZ (1) NZ244390A (no)
PT (1) PT533281E (no)
RU (1) RU2116071C1 (no)
SK (1) SK280283B6 (no)
ZA (1) ZA927157B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0402473B1 (en) * 1988-10-31 1994-05-11 Sumitomo Cement Co. Ltd. Antireflection articles, process for their production and coating composition
EP0703782A1 (en) * 1993-06-15 1996-04-03 Pfizer Inc. H2-antagonists as immune stimulants in bacterial infections of cattle or swine
EP0995447A1 (en) 1993-09-09 2000-04-26 Takeda Chemical Industries, Ltd. Formulation comprising antibacterial substance and antiulcer substance
TW420610B (en) * 1994-04-07 2001-02-01 Pfizer A pharmaceutical composition for treating a H. pylori infection or gastric or duodenal ulcers
US5795871A (en) * 1994-04-26 1998-08-18 Nobuhiro Narita Pharmaceutical composition for treatment of non-small cell lung cancer
GB9501560D0 (en) * 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
CN1177357A (zh) * 1995-01-26 1998-03-25 耐克麦德英梅金公司 铋化合物
US5981522A (en) * 1995-09-01 1999-11-09 Kaneka Corporation Treatment of disease caused by infection of Helicobacter
KR970032861A (ko) * 1995-12-29 1997-07-22 김준웅 헬리코박터 피로리 제거용 약제 투여방법
US5900410A (en) * 1996-08-27 1999-05-04 Hartmann; John F. Monotherapy of peptic ulcers and gastritis
DE19709897A1 (de) * 1997-03-11 1998-09-17 Hoechst Ag Wismutsalze von Antibiotika der Moenomycin-Gruppe, Verfahren zu ihrer Herstellung, ihre Verwendung und solche Salze enthaltende Arzneimittel
US6017950A (en) * 1997-08-05 2000-01-25 Millennium Pharmaceuticals, Inc. Methods for controlling gram negative bacteria in mammals
IT1296980B1 (it) * 1997-12-17 1999-08-03 Istituto Pirri S R L Capsula doppia come forma farmaceutica per la somministrazione di principi attivi in terapie multiple
AU3668000A (en) * 1999-04-29 2000-11-17 Russinsky Limited Compounds
WO2001064224A1 (en) * 2000-02-29 2001-09-07 Teva Pharmaceutical Industries Ltd. Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
US7670612B2 (en) * 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
CA2519458A1 (en) 2003-03-17 2004-09-30 Japan Tobacco Inc. Method for increasing the oral bioavailability of s-[2-([[1-(2-ethylbutyl)cyclohexyl]carbonyl]amino)phenyl]-2-methylpropanethioate
US20060194748A1 (en) * 2005-02-28 2006-08-31 National University Corporation Nagoya University Methods for treating disorders induced by H. pylori infections and pharmaceutical compositions for the same
CA2886042C (en) 2012-09-28 2015-11-24 Santen Pharmaceutical Co., Ltd. Therapeutic or preventive agent for meibomian gland dysfunction or meibomian gland blockage
US10201518B2 (en) 2016-09-28 2019-02-12 The University Of Hong Kong Bismuth(III) compounds and methods thereof
JP2021533173A (ja) 2018-08-31 2021-12-02 コリア インスティチュート オブ ジオサイエンス アンド ミネラル リソースズ 非吸収性抗生物質及び粘土鉱物の複合体を含む組成物を対象に経口投与するステップを含む、ヘリコバクター・ピロリの除菌方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB772567A (en) * 1954-05-06 1957-04-17 Siegfried Fischl Preparation of stable, injectable bismuth-containing pharmaceutical compositions and the compositions formed thereby
SG72632A1 (en) * 1985-04-18 2000-05-23 Procter & Gamble Treatment of non-ulcer dyspepsia with bismuth salts
US5256684A (en) * 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
DE3650504T2 (de) * 1985-06-13 1996-10-31 Marshall Barry James Verfahren und Zusammensetzungen zur Behandlung von gastrointestinalen Störungen
US4959384A (en) * 1985-10-24 1990-09-25 Norwich Eaton Pharmaceuticals, Inc. Use of nitrofurantoin for the treatment and prophylaxis of gastrointestinal disorders
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
DE3874917T2 (de) * 1987-03-09 1993-03-04 Procter & Gamble Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
DE3887353T2 (de) * 1987-10-12 1994-05-05 Capability Services Pty Ltd Behandlungsverfahren für magen-darm-krankheiten.
CH679582A5 (no) * 1988-07-18 1992-03-13 Glaxo Group Ltd
FI910088A (fi) * 1990-01-09 1991-07-10 Gist Brocades Nv Oral farmaceutisk komposition.
YU45590A (sh) * 1990-03-07 1992-07-20 PLIVA FARMACEVTSKA, KEMIJSKA, PREHRAMBENA I KOZMETIČKA INDUSTRIJA s.p.o. Novi kompleksi odnosno helati antibiotika s dvovalentnim i/ili trovalentnim metalima i postupci za njihovo dobijanje
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
WO1992010302A1 (de) * 1990-12-04 1992-06-25 Mueller Werner Bewässerungsanlage für hallenböden von reithallen, treibhäusern u. dgl.
US5176698A (en) * 1991-01-09 1993-01-05 Scimed Life Systems, Inc. Vented dilatation cathether and method for venting
US5128140A (en) * 1991-01-14 1992-07-07 The Procter & Gamble Company Swallowable pharmaceutical compositions

Also Published As

Publication number Publication date
AU663520B2 (en) 1995-10-12
CZ287892A3 (en) 1993-12-15
PT533281E (pt) 2003-04-30
NO301456B1 (no) 1997-11-03
NO923643L (no) 1993-03-22
EP0533281A1 (en) 1993-03-24
NZ244390A (en) 1997-06-24
ZA927157B (en) 1993-06-15
DE69232864T2 (de) 2003-11-20
IL103213A (en) 2000-02-29
FR2682040B1 (fr) 1994-10-28
GB9120131D0 (en) 1991-11-06
JPH0692850A (ja) 1994-04-05
KR930005619A (ko) 1993-04-20
GB2259647B (en) 1995-11-29
ATE228835T1 (de) 2002-12-15
CA2078579A1 (en) 1993-03-21
BE1005808A5 (fr) 1994-02-01
CY2012A (en) 1998-02-20
HU211170A9 (en) 1995-11-28
ES2188582T3 (es) 2003-07-01
IE922673A1 (en) 1993-03-24
IT1262993B (it) 1996-07-23
FR2682040A1 (fr) 1993-04-09
NO923643D0 (no) 1992-09-18
RU2116071C1 (ru) 1998-07-27
US5668130A (en) 1997-09-16
EP0533281B1 (en) 2002-12-04
SK280283B6 (sk) 1999-11-08
US5674858A (en) 1997-10-07
AT403656B (de) 1998-04-27
GB2259647A (en) 1993-03-24
IL103213A0 (en) 1993-02-21
MX9205313A (es) 1993-04-01
CZ282840B6 (cs) 1997-10-15
ATA186692A (de) 1997-09-15
GB9219749D0 (en) 1992-10-28
DE69232864D1 (de) 2003-01-16
AU2458492A (en) 1993-03-25
KR100257367B1 (ko) 2000-05-15
ITRM920681A1 (it) 1994-03-18
ITRM920681A0 (it) 1992-09-18
SK287892A3 (en) 1995-06-07
US5629297A (en) 1997-05-13
CH685372A5 (fr) 1995-06-30

Similar Documents

Publication Publication Date Title
GB2259647B (en) Medicaments for treating gastrointestinal disorders
EP0494972A4 (en) Effervescent dosage form and method of administering same
IE862554L (en) Pharmaceutical compositions
ZA895936B (en) Pharmaceutical compositions comprising selected lactobacillus strains
IL84834A0 (en) Pharmaceutical compositions containing certain n-(1-azabicyclo(2.2.2)oct-3-yl)-benzamides and thiobenzamides
MY108146A (en) Medicaments for treating inflammatory conditions or for analgesia
NZ225950A (en) Calcium citrate malate in the molar ratio of 6:2:3; pharmaceutical compositions
AU581853B2 (en) Coumarin derivatives, pharmaceutical compositions containing the same, and the use thereof in the treatment of cancer
DK0437294T3 (da) Orale farmaceutiske præparater i enhedsdosisform
PT86539A (en) Pharmaceutical composition for the prophylaxis and therapy of gastric ulcer
IL67940A0 (en) 2,3-diaryl-5-halo-thiophenes,their preparation and pharmaceutical compositions containing them
IL85388A0 (en) Pharmaceutical compositions containing oxoquinazoline derivatives for the treatment of hyperuricaemia
IL88658A0 (en) 8,9-annelated beta-carbolines and 3,4-dihydro-beta-carbolines,their preparation and pharmaceutical compositions containing them
NZ221542A (en) (4,2,0) bicyclooctane derivatives and pharmaceutical compositions
IL94621A0 (en) Pharmaceutical compositions containing vitamin a in association with various therapeutically active ingredients
GB8819626D0 (en) Pharmaceutical composition for treatment of tumours
ITMI913248A1 (it) Composizioni terapeutiche adatte per la somministrazione orale contenenti come principio attivo uno o piu' tioesteri del glutatione e procedimento per la preparazione dei suddetti principi attivi
GB8709860D0 (en) Pharmaceutical compositions & treatment
GB8709862D0 (en) Pharmaceutical compositions & treatment
GB8709861D0 (en) Pharmaceutical compositions & treatment
ZA882111B (en) 2,3-dideoxynucleosides and pharmaceutical compositions comprising same

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20060918